Powder: -20°C for 3 years | In solvent: -80°C for 1 year
FA16 是一种选择性、代谢稳定的铁死亡 (ferroptosis) 诱导剂 ,IC50 值为1.26 μM。FA16 是 2-(三氟甲基) 苯并咪唑的衍生物。FA16 对胱氨酸/谷氨酸反转运蛋白 (system Xc-) 介导了细胞内谷氨酸和细胞外胱氨酸的交换有抑制作用。FA16 在 HepG2 异种移植瘤模型中显著抑制肿瘤生长。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 1,300 | 现货 | ||
5 mg | ¥ 2,920 | 现货 | ||
10 mg | ¥ 4,290 | 现货 | ||
25 mg | ¥ 6,890 | 现货 | ||
50 mg | ¥ 9,320 | 现货 | ||
100 mg | ¥ 12,500 | 现货 | ||
500 mg | ¥ 24,900 | 现货 |
产品描述 | FA16 is a selective, metabolically stable ferroptosis inducer with an IC50 value of 1.26 μM.FA16 is a derivative of 2-(trifluoromethyl)benzimidazole.FA16 inhibits the cystine/glutamate inverse transporter protein (system Xc-)-mediated exchange of intracellular glutamate for extracellular cystine.FA16 significantly inhibited tumor growth in a HepG2 xenograft tumor model. HepG2 xenograft tumor model significantly inhibited tumor growth. |
靶点活性 | Ferroptosis (HT1080 cells):1.26 μM |
体外活性 |
FA16 (1 μM; 5 min) has satisfactory metabolic stability in rat and human liver microsomes.[1] FA16 (5 μM; 10 h) induces lipid ROS accumulation and inhibits glutamate release in HT1080 cells.[1] FA16 (5 μM; 24 h) resulted in mitochondrial atrophy and increased membrane density, consistent with morphological characteristics related to iron failure.[1] Ferroptosis induced by FA16 (10 μM; 24 h) can be rescued by the iron-shedding inhibitors Fer-1, Trolox, or DFO, whereas apoptosis or necrosis inhibitors are ineffective.[1] |
体内活性 | FA16 (15 or 30 mg/kg; intraperitoneal injection; administered every other day for 21 days; BALB/c nude mice bearing HepG2 tumors (s.c.)) significantly inhibited tumor growth in the 786-O xenograft mouse model with TGI value of 47.6% and 77.1% at 15 and 30 mg/kg, respectively. FA16 was safe (did not cause weight loss), and also induced Ferroptosis occurs in tumor tissue.[1] |
别名 | FA 16, FA-16 |
分子量 | 468.54 |
分子式 | C22H27F3N4O2S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.69 mg/mL (10 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1343 mL | 10.6714 mL | 21.3429 mL | 53.3572 mL |
5 mM | 0.4269 mL | 2.1343 mL | 4.2686 mL | 10.6714 mL | |
10 mM | 0.2134 mL | 1.0671 mL | 2.1343 mL | 5.3357 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
FA16 Apoptosis Ferroptosis FA 16 FA-16 Inhibitor inhibitor inhibit